In contrast, among those who received 80 mg /
m2 docetaxel, 12 months of trastuzumab had superior disease - free survival.
Disease - free survival was similar in the 9 - week and 12 - month arms among those patients who received 100 mg /
m2 docetaxel.
Not exact matches
Patients received 3 cycles of
docetaxel at either 80 mg /
m2 or 100 mg /
m2 and trastuzumab three times a week followed by 3 cycles of chemotherapy.